Exclusive: Warby Parker Seeks to Raise $75 Million
Warby Parker is looking to raise $75 million for its Series E round of financing, Cheddar has learned.
The eyewear company disclosed its plans to raise money in a filing with the state of Delaware on March 7 that was signed by its president Neil Blumenthal and provided to Cheddar by [Lagniappe Labs](https://primeunicornindex.com/).
A spokesperson for Warby Parker didn't respond to a request for comment.
The company last raised $100 million in 2015 for its Series D at a $1.2 billion valuation. It's is seeking a higher share price for its Series E, which indicates that its valuation will likely be higher after it completes the financing round.
Since last raising money, Warby Parker has significantly expanded its retail footprint and plans to have nearly 100 stories open in the U.S. by the end of 2018. Last year it opened a $16 million optical lab dedicated to building its own glasses in-house. And in January, it started selling products for kids for the first time.
Warby Parker has raised $216 million in total since its founding in 2010 from investors such as General Catalyst, T. Rowe Price, and Lerer Hippeau Ventures.
*Reporting by Alex Heath*
Paul Dergarabedian, Head of Marketplace Trends for Comscore, joins to discuss Disney earnings, industry leadership shifts and the 2026 box office outlook today.
The new space race isn't about just astronauts, it's about data. Hawkeye 360 CEO John Serafini on satellites, national security, and the company's recent IPO.
Voyager Technologies CEO Dylan Taylor discusses the booming commercial space race, NASA partnerships, defense tech, and building the future beyond Earth.
Inflation is outrunning growth, squeezing consumers and raising fear of a summer slowdown as high rates and sticky prices test spending and markets today now.
TIME's editorial director Emma Barker unpacks the 2026 100 Most Influential Companies list, spotlighting trends, AI impact, surprises, and leadership shifts.
From dire wolves to new species targets, scientists at Colossal Biosciences are using gene editing to revive extinction and reshape biodiversity as we know it.
